What was Sumitomo Chemical's FY2025 net income, and what were the main drivers behind its 58% year-on-year increase?

Sumitomo Chemical's FY2025 net income surged 58% year-on-year to ¥60.9 billion ($387 million), primarily driven by a recovery in its Essential & Green Materials (E&GM) segment — which returned to profitability with core operating income of ¥14.4 billion — and strong pharmaceutical earnings; the E&GM turnaround was specifically supported by improved trade terms for synthetic resins and a gain from the sale of a portion of the company’s shares in Petro Rabigh.

How does Sumitomo Chemical project its FY2026 financial performance, and what key risks did it highlight in its outlook?

Sumitomo Chemical forecasts a 14.9% year-on-year increase in net income to ¥70.0 billion for FY2026, with group sales revenue projected to rise 1.4% to ¥2.36 trillion and core operating income expected to grow 3.2% to ¥215.0 billion; however, the company cautioned that 'there remains a high degree of uncertainty regarding the outlook for rising raw material prices and potential impacts on the supply chain stemming from heightened geopolitical risks in the Middle East.'

Sumitomo Chemical FY2025 Net Income Surges on Petro Rabigh Share Sale

May 14, 2026

Sumitomo Chemical reported a 58% surge in FY2025 net income driven by its Essential & Green Materials segment recovery and gains from selling Petro Rabigh shares. The company forecasts a 14.9% increase in net income for FY2026 amid raw material price uncertainties.

icis

2026-05-14

Sumitomo Chemical FY2025 Net Income Surges on Petro Rabigh Share Sale

Sumitomo Chemical FY2025 Net Income Surges on Petro Rabigh Share Sale

FAQ